Highlights and Quick Summary
- EBT margin for the quarter ending November 30, 2022 was 11.77% (a -182.54% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin decreased by -190.4%
- Annual EBT margin for 2022 was -9.86% (a -94.03% decrease from previous year)
- Annual EBT margin for 2021 was -165.11% (a -2.27% decrease from previous year)
- Annual EBT margin for 2020 was -168.94% (a 2211.08% increase from previous year)
- Twelve month EBT margin ending November 30, 2022 was -5.28% (a -46.45% decrease compared to previous quarter)
- Twelve month trailing EBT margin decreased by -84.55% year-over-year
Trailing EBT margin for the last four month:
| 30 Nov '22 | 31 Aug '22 | 31 May '22 | 28 Feb '22 |
|---|---|---|---|
| -5.28% | -9.86% | -28.18% | -34.18% |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of Organigram Holdings Inc.
Most recent EBT marginof OGI including historical data for past 10 years.Interactive Chart of EBT margin of Organigram Holdings Inc.
Organigram Holdings Inc. EBT margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 11.77% | -14.26% | -6.5% | -13.02% | -9.86% |
| 2021 | -4.3% | -108.33% | -19.72% | -453.38% | -165.11% |
| 2020 | -177.62% | -209.15% | -554.05% | -32.43% | -168.94% |
| 2019 | -2.63% | -178.34% | -50.21% | -26.01% | -7.31% |
| 2018 | – | – | 340.08% | 100.0% | 223.48% |
| 2017 | – | – | – | – | -200.65% |
| 2016 | – | – | – | – | 13.82% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic